Grade 3–4 elevation of serum alanine aminotransferase (ALT) and/or aspartate aminotransferase (AST) in 12–17%, and isolated hyperbilirubinemia in 36% of patients is observed at administered dose of 800 mg daily. This evidence concerns the gene GPT and Hyperbilirubinemia.